Search results
Ivonescimab shows promise in NSCLC Phase III trial By Investing.com
Investing.com· 9 hours agoSummit Therapeutics Inc. (NASDAQ: NASDAQ:SMMT) announced that its Phase III clinical trial,...
Untapped opportunities: Fulfilling the promise of decentralized clinical trials
Medical Device Network via Yahoo Finance· 19 hours agoDCTs and hybrid digital trials are on the rise – and are driving new complexities in clinical trial...
Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial
Clinical Trials Arena via Yahoo Finance· 19 hours agoLexicon Pharmaceuticals has chosen clinical trial solutions provider Medidata to help advance the ...
ICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
Investing.com· 2 days agoICMR, NIV to start phase-3 clinical trials of recombinant dengue vax: Centre
...Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929...
FOX 5 San Diego· 7 days agoThe data will be presented in a poster at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO 2024) on June 2, 2024.
NS Pharma Shares Preliminary Results of Viltolarsen (NS-065 / NCNP-01) Phase 3 Clinical Trial...
Morningstar· 4 days agoNS Pharma, Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd., announced today that it has received preliminary analysis results from the global Phase< ...
COVID can cause new health problems to appear years after infection, according to a study of more...
Fortune via Yahoo Finance· 19 hours agoThat is a higher incidence than either heart disease or cancer. “People are developing new onset...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 7 days ago(NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing...
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 1 day agoThis decision comes after recent consultations with the U.S. Food and Drug Administration (FDA) and...
Summit Therapeutics’ stock surges as lung-cancer treatment vies with Merck’s blockbuster
Market Watch· 8 hours agojumped more than 270% Thursday after the company said its experimental cancer drug outperformed...